PHOTOCURE ASA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56 NOK | -1.23% |
|
+3.90% | -16.91% |
Chart calendar Photocure ASA
41af4d.ZZAi9IN6ncRGTno5TbyRSLrtENgO4WJENltdd_h92oY.VMNWzdcu9qAfJx1besXJANO0VZJpsRMxfDxuJKlFucw_6GWVtU3wkjZ5CQ~1abfa82f898e06882deb622b695031c2
Upcoming events on Photocure ASA
Past events on Photocure ASA
| 11/04/2024 13:00 | Needham Healthcare Conference |
| 08/04/2024 11:30 | European Association of Urology Congress |
| 07/04/2024 16:15 | European Association of Urology Congress |
| 16/03/2024 | Society of Gynecologic Oncology on Womens Cancer Meeting |
| 12/03/2024 | European Research Organization on Genital Infection and Neoplasia Congress - Abstract No.6802 |
| 21/02/2024 13:00 | Q4 2023 Earnings Call |
| 21/02/2024 07:15 | Q4 2023 Earnings Release |
| 25/01/2024 | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 14/12/2023 14:35 | DNB Nordic Healthcare Conference |
| 06/12/2023 19:30 | Nordic- American Healthcare Conference |
| 29/11/2023 | Society of Urologic Oncology Meeting |
| 28/11/2023 14:50 | Piper Sandler Healthcare Conference |
| 22/11/2023 09:40 | SEB Healthcare Seminar |
| 15/11/2023 | DNB Nordic Healthcare Conference |
| 08/11/2023 13:00 | Q3 2023 Earnings Call |
| 08/11/2023 07:00 | Q3 2023 Earnings Release |
| 12/10/2023 11:45 | Society of Urology International Congress |
| 13/08/2023 | Needham Virtual MedTech & Diagnostics Conference |
| 09/08/2023 13:00 | Q2 2023 Earnings Call |
| 09/08/2023 07:00 | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 182 180 0.7% | 282 237 18.61% | 256 224 14.44% | 361 353 2.05% | 374 397 -5.61% | 446 468 -4.65% |
|
EBITDA Million NOK | Released Forecast Spread | -10,5 -10,9 3.8% | 59,0 40,7 44.84% | -3,91 -22,9 82.94% | 18,3 18,1 1.38% | -24,6 -9,48 -159.79% | 55,5 13,5 310.01% |
|
EBIT Million NOK | Released Forecast Spread | -23,7 -36,0 34.2% | 42,7 2,64 1518.52% | -23,2 -40,7 42.99% | -5,83 -6,08 4.25% | -49,0 -29,1 -68.29% | 27,8 12,8 116.93% |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -36,7 -29,5 -24.62% | 45,9 27,1 69.5% | -33,2 -53,3 37.66% | -31,7 -13,0 -143.83% | -71,1 -51,0 -39.61% | 9,74 -3,51 377.51% |
|
Net income Million NOK | Released Forecast Spread | -36,7 -29,4 -24.84% | 31,8 14,9 113.88% | -22,4 -46,5 51.82% | -30,9 -15,1 -104.78% | -71,9 -54,5 -31.8% | 0,27 -8,47 103.15% |
|
EPS NOK | Released Forecast Spread | -1,70 -1,37 -24.09% | 1,46 0,69 113.14% | -0,91 -1,88 51.6% | -1,15 -0,56 -105.19% | -2,66 -2,03 -31.08% | 0,01 -0,31 103.21% |
| Announcement Date | 27/02/19 | 27/02/20 | 03/03/21 | 23/02/22 | 23/02/23 | 21/02/24 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 87,4 91,3 -4.22% | 94,5 90,4 4.56% | 81,6 93,0 -12.25% | 101 98,2 2.45% | 107 106 0.99% | 94,9 112 -15.44% | 106 103 2.97% | 144 117 23.81% | 108 113 -4.56% | 115 123 -6.61% | 115 | 147 | 117 | 129 |
|
EBITDA Million NOK | Released Forecast Spread | -0,20 1,70 -111.76% | -5,47 -2,59 -111.36% | -13,9 -4,00 -247% | 1,40 -1,93 172.57% | 4,70 1,64 187.08% | -16,9 2,92 -678.63% | -1,20 -10,0 88% | 23,4 2,72 759.4% | 3,34 -5,39 161.92% | 29,9 1,25 2297.51% | 3,00 | 30,0 | 0,00 | 11,0 |
|
EBIT Million NOK | Released Forecast Spread | -6,34 -4,40 -44.18% | -11,5 -8,77 -31.09% | -19,9 -10,0 -98.8% | -4,60 -7,93 41.99% | -1,40 -4,37 67.95% | -23,1 -3,15 -632.86% | -7,70 -16,2 52.51% | 16,8 -3,58 570.44% | -3,85 -9,17 58% | 22,5 7,65 193.7% | -5,00 | 23,0 | -7,00 | 4,00 |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -11,4 -10,2 -12.31% | -33,0 -14,2 -133.09% | -27,3 -15,5 -75.85% | -9,05 -13,4 32.59% | -6,26 -4,87 -28.61% | -28,6 -8,15 -250.4% | -10,1 -20,2 50.03% | 12,0 -7,13 267.69% | -8,67 -13,8 37.07% | 16,6 3,31 400.71% | -5,50 | 25,0 | -5,00 | 6,00 |
|
Net income Million NOK | Released Forecast Spread | -7,30 -7,90 7.58% | -28,2 -11,1 -154.2% | -22,0 -12,0 -83.21% | -18,5 -10,5 -75.52% | -9,93 -3,80 -161.53% | -21,5 -6,35 -238.43% | -11,7 -16,1 27.19% | 4,31 -5,62 176.73% | -4,79 -10,8 55.85% | 12,5 2,86 336.86% | -4,50 | 20,0 | -4,00 | 5,00 |
|
EPS NOK | Released Forecast Spread | -0,27 -0,30 8.47% | -1,05 -0,41 -155.67% | -0,82 -0,47 -76.34% | -0,68 -0,39 -73.55% | -0,37 -0,15 -152.59% | -0,79 -0,24 -234.6% | -0,43 -0,58 26.3% | 0,16 -0,21 176.75% | -0,18 -0,40 54.95% | 0,46 0,11 325.22% | -0,08 | 0,72 | -0,15 | 0,17 |
| Announcement Date | 17/11/21 | 23/02/22 | 11/05/22 | 10/08/22 | 02/11/22 | 23/02/23 | 10/05/23 | 09/08/23 | 08/11/23 | 21/02/24 | - | - | - | - |
| 30/04/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 07:00 | GSK PLC: Q1 2024 Earnings Release |
| 01/05/2024 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 01/05/2024 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 01/05/2024 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 01/05/2024 | AMGEN INC.: Q1 2024 Earnings Release |
Past sector events for Photocure ASA
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHO Stock
- Calendar Photocure ASA
